Deutsche Bank Provides Color on Pharmaceuticals

Deutsche Bank provided color on the pharmaceuticals sector. In a research report published today, Deutsche Bank named Pfizer PFE, Merck MRK and Bristol Myers Squibb BMY, all Buy-rated, as its top picks. On Friday, BMY lost 0.45% of its value to finish the day at $28.97. Its shares continued to slide in today's pre-market trading, falling 0.28% to $28.89. At the same time, MRK lost 1.05% of its value on Friday to end the week at $35.93. Its shares continued to slide in today's pre-market trading, falling 0.72% to stand around $35.65. Finally, Pfizer lost 0.8% on Friday to close the day at $19.75. Its shares also continued to slide in today's pre-market trading, falling 0.46% of its value to stand around $19.66.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsDeutsche BankHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!